-
Founded in:
1997-10-17 -
Country:
China -
Address:
No. 219, Qing'an Road, Xinzheng City -
Tax NO.:
91410100712635557P -
Registered Funds:
111.68 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fluconazole |
This product belongs to the azole antifungal drug with a wide antifungal spectrum. Its mechanism of action is mainly to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane. It is effective against a variety of fungal infections, including Candida infection, Cryptococcus neoformans infection, etc.
More
This product belongs to the azole antifungal drug with a wide antifungal spectrum. Its mechanism of action is mainly to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane. It is effective against a variety of fungal infections, including Candida infection, Cryptococcus neoformans infection, etc. |
86386-73-4 | 69 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| FRITILLARIAE THUNBERGII BULBUS |
|
0 | ||
| Paeoniae Rubra |
|
0 | ||
| Bupleurum |
|
0 | ||
| Prunella vulgaris |
|
0 | ||
| CURCUMAE RADIX |
|
0 | ||
| Angelicae Sinensis Radix |
|
0 | ||
| Swisscentaury Root Extract |
|
0 | ||
| Semen Citri Reticulatae extract |
|
0 | ||
| CYPERI RHIZOMA |
|
0 | ||
| Rubiae Radix et Rhizoma |
|
0 | ||
| LUFFAE FRUCTUS RETINERVUS |
|
0 | ||
| DGL |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Enoxacin |
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.
More
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. |
74011-58-8 | 4 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vitamin K1 |
This product is a vitamin drug. Vitamin K is a necessary substance for the liver to synthesize factors II, VII, IX, and X. Vitamin K deficiency can cause synthesis disorders or abnormalities of these coagulation factors, and clinically bleeding tendency and prolonged prothrombin time can be seen.
More
This product is a vitamin drug. Vitamin K is a necessary substance for the liver to synthesize factors II, VII, IX, and X. Vitamin K deficiency can cause synthesis disorders or abnormalities of these coagulation factors, and clinically bleeding tendency and prolonged prothrombin time can be seen. |
84-80-0 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tinidazole |
It has high activity against protozoa and anaerobic bacteria, and can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; the mechanism of anti-amoeba is to inhibit its redox reaction, break the nitrogen chain of the protozoa, and thus kill the protozoa. It reduces to cytotoxicity and acts on the bacterial DNA metabolism process, causing bacterial death.
More
It has high activity against protozoa and anaerobic bacteria, and can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; the mechanism of anti-amoeba is to inhibit its redox reaction, break the nitrogen chain of the protozoa, and thus kill the protozoa. It reduces to cytotoxicity and acts on the bacterial DNA metabolism process, causing bacterial death. |
19387-91-8 | 13 |